PX855 Citations (3)
Originally described in: A split-Cas9 architecture for inducible genome editing and transcription modulation.Zetsche B, Volz SE, Zhang F Nat Biotechnol. 2015 Feb 2. doi: 10.1038/nbt.3149. PubMed Journal
Articles Citing PX855
Articles |
---|
Engineering Synthetic Signaling Pathways with Programmable dCas9-Based Chimeric Receptors.
Baeumler TA, Ahmed AA, Fulga TA.
Cell Rep. 2017 Sep 12;20(11):2639-2653. doi: 10.1016/j.celrep.2017.08.044.
PubMed
Associated Plasmids |
Multimode drug inducible CRISPR/Cas9 devices for transcriptional activation and genome editing.
Lu J, Zhao C, Zhao Y, Zhang J, Zhang Y, Chen L, Han Q, Ying Y, Peng S, Ai R, Wang Y.
Nucleic Acids Res. 2018 Mar 16;46(5):e25. doi: 10.1093/nar/gkx1222.
PubMed
Associated Plasmids |
Spatial and temporal control of gene manipulation in Drosophila via drug-activated Cas9 nucleases. Huynh N, Wang S, King-Jones K. Insect Biochem Mol Biol. 2020 May;120:103336. doi: 10.1016/j.ibmb.2020.103336. Epub 2020 Feb 24. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.